首页 > 最新文献

Bulletin et memoires de l'Academie royale de medecine de Belgique最新文献

英文 中文
[Magnetic resonance imaging for quantifying hepatis steatosis and hepatic fibrosis]. [磁共振成像定量肝脂肪变性和肝纤维化]。
B Van Beers

The reference method for detecting and quantifying hepatic steatosis and fibrosis is the histopathological analysis of liver biopsies. Studies performed in animals and humans have shown that magnetic resonance imaging (MRI) is useful for the accurate and non-invasive quantification of these lesions. For fibrosis quantification, functional MRI methods have to be used, including perfusion MRI, diffusion MRI, and more particularly MR elastography. Modifications of the visco-elastic parameters of the liver can also be observed with MR elastography in hepatic diseases without fibrosis, such as the early stages ofnon-alcoholi steatohepatitis. Finally, accurate quantification of liver steatosis can be performed by observing the difference of resonance frequencies between the protons of fat and water at spectroscopy or chemical shift MRI. In conclusion, combined quantification of liver steatosis and fibrosis can be performed with MRI.

检测和定量肝脂肪变性和肝纤维化的参考方法是肝活检的组织病理学分析。在动物和人类身上进行的研究表明,磁共振成像(MRI)对于这些病变的准确和非侵入性量化是有用的。对于纤维化量化,必须使用功能性MRI方法,包括灌注MRI,弥散MRI,特别是MR弹性成像。在无纤维化的肝脏疾病,如非酒精性脂肪性肝炎的早期阶段,也可以用MR弹性成像观察到肝脏粘弹性参数的改变。最后,通过在光谱或化学位移MRI上观察脂肪和水质子之间的共振频率差异,可以对肝脏脂肪变性进行准确的定量。总之,MRI可以对肝脂肪变性和肝纤维化进行联合定量。
{"title":"[Magnetic resonance imaging for quantifying hepatis steatosis and hepatic fibrosis].","authors":"B Van Beers","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The reference method for detecting and quantifying hepatic steatosis and fibrosis is the histopathological analysis of liver biopsies. Studies performed in animals and humans have shown that magnetic resonance imaging (MRI) is useful for the accurate and non-invasive quantification of these lesions. For fibrosis quantification, functional MRI methods have to be used, including perfusion MRI, diffusion MRI, and more particularly MR elastography. Modifications of the visco-elastic parameters of the liver can also be observed with MR elastography in hepatic diseases without fibrosis, such as the early stages ofnon-alcoholi steatohepatitis. Finally, accurate quantification of liver steatosis can be performed by observing the difference of resonance frequencies between the protons of fat and water at spectroscopy or chemical shift MRI. In conclusion, combined quantification of liver steatosis and fibrosis can be performed with MRI.</p>","PeriodicalId":75641,"journal":{"name":"Bulletin et memoires de l'Academie royale de medecine de Belgique","volume":"164 1-2","pages":"44-50; discussion 51-2"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28372426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Embryonic development of the liver: basic biology and pediatric pathology]. [肝脏的胚胎发育:基础生物学和儿科病理学]。
F Lemaigre

At birth a number of children suffer from hepatic enzyme deficiencies or from biliary malformations. These diseases can be better understood, and in some instances better treated, with the help of knowledge gained from developmental biology studies. Here we review the key steps of liver development and illustrate how developmental biology can contribute to improve diagnosis and treatment of hepatic diseases, and at the same, time benefits from the input from clinical sciences.

出生时,许多儿童患有肝酶缺乏或胆道畸形。借助从发育生物学研究中获得的知识,可以更好地了解这些疾病,在某些情况下还可以更好地治疗这些疾病。在这里,我们回顾了肝脏发育的关键步骤,并说明了发育生物学如何有助于改善肝脏疾病的诊断和治疗,同时从临床科学的投入中获益。
{"title":"[Embryonic development of the liver: basic biology and pediatric pathology].","authors":"F Lemaigre","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>At birth a number of children suffer from hepatic enzyme deficiencies or from biliary malformations. These diseases can be better understood, and in some instances better treated, with the help of knowledge gained from developmental biology studies. Here we review the key steps of liver development and illustrate how developmental biology can contribute to improve diagnosis and treatment of hepatic diseases, and at the same, time benefits from the input from clinical sciences.</p>","PeriodicalId":75641,"journal":{"name":"Bulletin et memoires de l'Academie royale de medecine de Belgique","volume":"164 1-2","pages":"39-42; discussion 43"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28372425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[HLA-G: from feto-maternal tolerance to organ grafting]. [HLA-G:从胎母耐受到器官移植]。
E D Carosella

E.D. Carosella was the pioneer who demonstrated the protective role of the HLA-G molecule on trophoblasts, which form a shield protecting the fetus from the immune reaction of its mother and subsequent reject. This non-classical HLA class I molecule is first expressed on the fertilized ovocyte, thus enabling a uterine implantation and then on the surface of the placenta trophoblast where the classical class I and II antigens are absent. He brought the first demonstration ex vivo of the protector role of HLA-G molecule present on the surface of fetal cytotrophoblast cells versus the lysis carried out by maternal decidual uterine NK cells, in both semi-allogenic combinations (maternal uterine NK cells and their own fetal cytotropohoblast counterparts) and allogenic combinations (different maternal uterine NK cells and cytotrophoblasts from different fetuses). The blockage of this protein triggers off an important cytotoxicity towards the fetal cells. Furthermore, he showed that HLA-G molecules act as an inhibitor of the T-lymphocytes, NK cells and antigen presenting cells (APC). Through his discovery Carosella also shows for the first time the three major clinical consequences: I) HLA-G molecules are crucial, as an altered expression of these molecules would lead to abortion and failed pregnancies, i.e. recurrent spontaneous abortions and preeclamptic disease. The embryo expression of soluble HLA-G molecules is a mandatory prerequisite to implantation. II) In allogenic transplantation (heart, kidney and liver-kidney graft) the expression of HLA-G protein significantly reduces acute rejection and showed an absence of chronic rejections. III) Finally, this expression on the malignant cells has a negative functional impact in the anti-tumour response. So the expression of HLA-G molecule constitutes an escape mechanism from immunosurveillance, just as the fetal cells protect themselves from the aggression of maternal immune cells.

卡罗塞拉(E.D. Carosella)是证明HLA-G分子对滋养细胞起保护作用的先驱,滋养细胞形成屏障,保护胎儿免受母亲的免疫反应和随后的排斥。这种非经典HLA I类分子首先在受精卵细胞上表达,从而使子宫着床成为可能,然后在缺乏经典I类和II类抗原的胎盘滋养细胞表面表达。他首次在体外证明了存在于胎儿细胞滋养层细胞表面的HLA-G分子对母体子宫蜕膜NK细胞进行溶解的保护作用,无论是半同种异体组合(母体子宫NK细胞和它们自己的胎儿细胞滋养层细胞)还是同种异体组合(来自不同胎儿的不同母体子宫NK细胞和细胞滋养层细胞)。这种蛋白质的阻断会对胎儿细胞产生重要的细胞毒性。此外,他还发现HLA-G分子可以作为t淋巴细胞、NK细胞和抗原呈递细胞(APC)的抑制剂。通过他的发现,Carosella也首次展示了三个主要的临床后果:1)HLA-G分子是至关重要的,因为这些分子的表达改变会导致流产和妊娠失败,即复发性自然流产和子痫前期疾病。胚胎中可溶性HLA-G分子的表达是胚胎着床的必要前提。II)在同种异体移植(心脏、肾脏和肝肾移植)中,HLA-G蛋白的表达可显著减少急性排斥反应,并无慢性排斥反应。III)最后,这种在恶性细胞上的表达对抗肿瘤反应有负面的功能影响。因此,HLA-G分子的表达构成了一种逃避免疫监视的机制,就像胎儿细胞保护自己免受母体免疫细胞的攻击一样。
{"title":"[HLA-G: from feto-maternal tolerance to organ grafting].","authors":"E D Carosella","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>E.D. Carosella was the pioneer who demonstrated the protective role of the HLA-G molecule on trophoblasts, which form a shield protecting the fetus from the immune reaction of its mother and subsequent reject. This non-classical HLA class I molecule is first expressed on the fertilized ovocyte, thus enabling a uterine implantation and then on the surface of the placenta trophoblast where the classical class I and II antigens are absent. He brought the first demonstration ex vivo of the protector role of HLA-G molecule present on the surface of fetal cytotrophoblast cells versus the lysis carried out by maternal decidual uterine NK cells, in both semi-allogenic combinations (maternal uterine NK cells and their own fetal cytotropohoblast counterparts) and allogenic combinations (different maternal uterine NK cells and cytotrophoblasts from different fetuses). The blockage of this protein triggers off an important cytotoxicity towards the fetal cells. Furthermore, he showed that HLA-G molecules act as an inhibitor of the T-lymphocytes, NK cells and antigen presenting cells (APC). Through his discovery Carosella also shows for the first time the three major clinical consequences: I) HLA-G molecules are crucial, as an altered expression of these molecules would lead to abortion and failed pregnancies, i.e. recurrent spontaneous abortions and preeclamptic disease. The embryo expression of soluble HLA-G molecules is a mandatory prerequisite to implantation. II) In allogenic transplantation (heart, kidney and liver-kidney graft) the expression of HLA-G protein significantly reduces acute rejection and showed an absence of chronic rejections. III) Finally, this expression on the malignant cells has a negative functional impact in the anti-tumour response. So the expression of HLA-G molecule constitutes an escape mechanism from immunosurveillance, just as the fetal cells protect themselves from the aggression of maternal immune cells.</p>","PeriodicalId":75641,"journal":{"name":"Bulletin et memoires de l'Academie royale de medecine de Belgique","volume":"164 3-4","pages":"87-99; discussion 99-101"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28682893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protein-protein interactions among ion channels regulate ion transport in the kidney. 离子通道之间的蛋白质-蛋白质相互作用调节肾脏中的离子运输。
E Boulpaep

Epithelial ion transport in various organs has long been known to be controlled by extracellular agonists acting via membrane receptors or by intracellular messengers. Evidence is mounting for regulation of transport by direct interaction among membrane proteins or between a membrane transport protein and membrane-attached proteins. The membrane protein CFTR (Cystic Fibrosis Transmembrane Regulator) is widely expressed along the length of the nephron, but its role as a chloride channel does not appear to be critical for renal handling of salt and water. It is well established that the inward rectifying K channels (ROMK = Kir 1.1) in the thick ascending limb of Henle and in principal cells of the collecting duct are inhibited by millimolar concentrations of cytosolic Mg-ATP. However, the mechanism of this inhibition has been an enigma. We propose that the ATP-Binding Cassette (ABC) protein CFTR is a cofactor for Kir 1.1 regulation. Indeed, Mg-ATP sensitivity of Kir 1.1 is completely absent in two different mouse models of cystic fibrosis. In addition, the open-closed state of CFTR appears to provide a molecular gating switch that prevents or facilitates the ATP sensing of Kir 1.1. Does Mg-ATP sensing by the CFTR- Kir 1.1 complex play a role in coupling metabolism to ion transport? Physiological intracellular ATP concentrations in tubule cells are in the millimolar range, a saturating concentration for the gating of Kir 1.1 by Mg-ATP. Therefore, Kir 1.1 channels would be closed and unable to contribute to regulation of potassium secretion unless some other process modulated the CFTR-dependent ATP-sensitivity of Kir 1.1. The third component of the metabolic sensor-effector complex for Kir 1.1 regulation is most likely the AMP-regulated serine-threonine kinase, AMP kinase (AMPK). Changing levels in AMP rather than in ATP constitute the metabolic signal "sensed" by tubule cells. Because AMPK inhibits CFTR by modulating CFTR channel gating, we propose that renal K secretion is physiologically regulated by tri-molecular interactions between Kir 1.1, CFTR and AMPK.

上皮离子在各种器官中的转运是由细胞外激动剂通过膜受体或细胞内信使控制的。越来越多的证据表明,通过膜蛋白之间或膜转运蛋白与膜附着蛋白之间的直接相互作用来调节转运。膜蛋白CFTR(囊性纤维化跨膜调节因子)沿着肾单位的长度广泛表达,但其作为氯离子通道的作用似乎对肾脏处理盐和水并不重要。已经确定,在Henle的厚升翼和收集管的主要细胞中,向内整流的K通道(ROMK = Kir 1.1)受到毫摩尔浓度的细胞质Mg-ATP的抑制。然而,这种抑制的机制一直是一个谜。我们认为atp结合盒(ABC)蛋白CFTR是Kir 1.1调控的辅助因子。事实上,在两种不同的囊性纤维化小鼠模型中,Kir 1.1的Mg-ATP敏感性完全缺失。此外,CFTR的开闭状态似乎提供了一个分子门控开关,阻止或促进Kir 1.1的ATP感应。CFTR- Kir 1.1复合物对Mg-ATP的感应是否在离子转运的耦合代谢中起作用?小管细胞的生理细胞内ATP浓度在毫摩尔范围内,这是Mg-ATP门控Kir 1.1的饱和浓度。因此,Kir 1.1通道将被关闭,无法参与钾分泌的调节,除非有其他过程调节Kir 1.1依赖cftr的atp敏感性。调节Kir 1.1的代谢传感器效应复合物的第三个组成部分最有可能是AMP调节的丝氨酸-苏氨酸激酶,AMP激酶(AMPK)。AMP水平的变化而不是ATP水平的变化构成了小管细胞“感知”的代谢信号。由于AMPK通过调节CFTR通道门控来抑制CFTR,我们提出肾脏K的分泌受到Kir 1.1、CFTR和AMPK之间的三分子相互作用的生理调节。
{"title":"Protein-protein interactions among ion channels regulate ion transport in the kidney.","authors":"E Boulpaep","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Epithelial ion transport in various organs has long been known to be controlled by extracellular agonists acting via membrane receptors or by intracellular messengers. Evidence is mounting for regulation of transport by direct interaction among membrane proteins or between a membrane transport protein and membrane-attached proteins. The membrane protein CFTR (Cystic Fibrosis Transmembrane Regulator) is widely expressed along the length of the nephron, but its role as a chloride channel does not appear to be critical for renal handling of salt and water. It is well established that the inward rectifying K channels (ROMK = Kir 1.1) in the thick ascending limb of Henle and in principal cells of the collecting duct are inhibited by millimolar concentrations of cytosolic Mg-ATP. However, the mechanism of this inhibition has been an enigma. We propose that the ATP-Binding Cassette (ABC) protein CFTR is a cofactor for Kir 1.1 regulation. Indeed, Mg-ATP sensitivity of Kir 1.1 is completely absent in two different mouse models of cystic fibrosis. In addition, the open-closed state of CFTR appears to provide a molecular gating switch that prevents or facilitates the ATP sensing of Kir 1.1. Does Mg-ATP sensing by the CFTR- Kir 1.1 complex play a role in coupling metabolism to ion transport? Physiological intracellular ATP concentrations in tubule cells are in the millimolar range, a saturating concentration for the gating of Kir 1.1 by Mg-ATP. Therefore, Kir 1.1 channels would be closed and unable to contribute to regulation of potassium secretion unless some other process modulated the CFTR-dependent ATP-sensitivity of Kir 1.1. The third component of the metabolic sensor-effector complex for Kir 1.1 regulation is most likely the AMP-regulated serine-threonine kinase, AMP kinase (AMPK). Changing levels in AMP rather than in ATP constitute the metabolic signal \"sensed\" by tubule cells. Because AMPK inhibits CFTR by modulating CFTR channel gating, we propose that renal K secretion is physiologically regulated by tri-molecular interactions between Kir 1.1, CFTR and AMPK.</p>","PeriodicalId":75641,"journal":{"name":"Bulletin et memoires de l'Academie royale de medecine de Belgique","volume":"164 3-4","pages":"133-41; discussion 141-2"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28682895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Unravelling the mechanisms of the biogenesis of the outer membrane of Gram-negative bacteria: a step toward the development of new antibiotics]. [揭示革兰氏阴性菌外膜的生物发生机制:迈向新抗生素开发的一步]。
J F Collet

The outer membrane of Gram negative bacteria such as Escherichia coli is a permeability barrier that is essential for the viability of Gram-negative bacteria and protects them against antimicrobial drugs, including hydrophobic antibiotics. Outer membrane components, including phospholipids, lipopolysaccharids and proteins are synthesized in the cytoplasm and the cytoplasmic membrane. The mechanisms by which unfolded proteins and lipids are then transported through the hydrophilic periplasm and are inserted in the outer membrane are essentially unknown. Our overall goal is to solve the fascinating problem of how such a complex macromolecular structure is assembled in a compartment devoid of obvious energy sources. Moreover, the proteins that are involved in OM biogenesis are also attractive targets for the design of new antibiotics and anti-inflammatory drugs. Developing new antibiotics active against E. coli and other Gram negative bacteria is criticial because the number of E. coli strains that are resistant to antibiotics is rapidly rising. We will describe results obtained recently in our laboratory that allowed us to characterize several periplasmic chaperones involved in the folding of envelope proteins.

革兰氏阴性菌(如大肠杆菌)的外膜是一种渗透性屏障,对革兰氏阴性菌的生存能力至关重要,并保护它们免受包括疏水抗生素在内的抗菌药物的侵害。外膜成分,包括磷脂、脂多糖和蛋白质在细胞质和细胞质膜中合成。未折叠的蛋白质和脂质通过亲水周质转运并插入外膜的机制基本上是未知的。我们的总体目标是解决这样一个令人着迷的问题:如此复杂的大分子结构是如何在一个没有明显能量来源的隔间中组装起来的。此外,参与OM生物发生的蛋白质也是设计新的抗生素和抗炎药物的有吸引力的靶点。开发针对大肠杆菌和其他革兰氏阴性菌的新型抗生素至关重要,因为对抗生素具有耐药性的大肠杆菌菌株数量正在迅速增加。我们将描述最近在我们实验室获得的结果,这些结果使我们能够表征参与包膜蛋白折叠的几种质周伴侣。
{"title":"[Unravelling the mechanisms of the biogenesis of the outer membrane of Gram-negative bacteria: a step toward the development of new antibiotics].","authors":"J F Collet","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The outer membrane of Gram negative bacteria such as Escherichia coli is a permeability barrier that is essential for the viability of Gram-negative bacteria and protects them against antimicrobial drugs, including hydrophobic antibiotics. Outer membrane components, including phospholipids, lipopolysaccharids and proteins are synthesized in the cytoplasm and the cytoplasmic membrane. The mechanisms by which unfolded proteins and lipids are then transported through the hydrophilic periplasm and are inserted in the outer membrane are essentially unknown. Our overall goal is to solve the fascinating problem of how such a complex macromolecular structure is assembled in a compartment devoid of obvious energy sources. Moreover, the proteins that are involved in OM biogenesis are also attractive targets for the design of new antibiotics and anti-inflammatory drugs. Developing new antibiotics active against E. coli and other Gram negative bacteria is criticial because the number of E. coli strains that are resistant to antibiotics is rapidly rising. We will describe results obtained recently in our laboratory that allowed us to characterize several periplasmic chaperones involved in the folding of envelope proteins.</p>","PeriodicalId":75641,"journal":{"name":"Bulletin et memoires de l'Academie royale de medecine de Belgique","volume":"164 7-9","pages":"213-20; discussion 220"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28765937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Male and female fertility too late? Effect of parental age at conception on the health and mortality of children]. 【男性和女性生育太晚?】父母受孕年龄对儿童健康和死亡率的影响[j]。
G Wunsch, C Gourbin

After recalling that maternal and paternal fertility, and in particular the first birth, are occurring later and later in life in all developed countries, the paper examines the relation between parental ages at childbearing on the one hand and morbidity and mortality of the child on the other hand. Age of mother at childbearing has an impact on child mortality and morbidity. Similarly, a late paternal age at childbearing, controlling for mother's age, has a statistically significant impact on neonatal mortality and on late foetal mortality, as well as on the risk for the child of suffering from various congenital anomalies.

在回顾了所有发达国家中,母亲和父亲的生育,特别是第一次生育,在生活中越来越晚,论文一方面检查了父母生育年龄与儿童发病率和死亡率之间的关系,另一方面。母亲的生育年龄对儿童死亡率和发病率有影响。同样,在控制母亲年龄的情况下,父亲晚育在统计上对新生儿死亡率和胎儿晚育死亡率以及儿童患各种先天性异常的风险有重大影响。
{"title":"[Male and female fertility too late? Effect of parental age at conception on the health and mortality of children].","authors":"G Wunsch,&nbsp;C Gourbin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>After recalling that maternal and paternal fertility, and in particular the first birth, are occurring later and later in life in all developed countries, the paper examines the relation between parental ages at childbearing on the one hand and morbidity and mortality of the child on the other hand. Age of mother at childbearing has an impact on child mortality and morbidity. Similarly, a late paternal age at childbearing, controlling for mother's age, has a statistically significant impact on neonatal mortality and on late foetal mortality, as well as on the risk for the child of suffering from various congenital anomalies.</p>","PeriodicalId":75641,"journal":{"name":"Bulletin et memoires de l'Academie royale de medecine de Belgique","volume":"164 7-9","pages":"221-31; discussion 231-3"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28765938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Regeneration of the liver: from hepatocyte cells to deficient hepatic cells]. [肝脏的再生:从肝细胞到缺陷肝细胞]。
E M Sokal

Regenerative medicine aims to restore the function of a deficient organ without replacing it, i.e. without resection-transplantation, but by the use of healthy cells which will transfer the deficient function inside the diseased organ. Cells can be mature, harvested directly from the source tissue, or be instead produced from stem cells, which can be manipulated in vitro, expanded and/or differentiated to render them functional. Liver cell therapy has brought the proof of concept that a deficient metabolic activity can be transferred via transfusion of heterologous liver cells via the portal vein. The main limitations of the technique include organ shortage, poor renewal capacity of mature cells and poor resistance to cryopreservation. A liver derived progenitor cell has recently been identified in the adult human liver. The cell is selected by a culture process, can be expanded in vitro and differentiated into mature human hepatocytes when transplanted in rodent livers. The cell displays all the essential hepatocyte function, and may replace the mature hepatocyte for regenerative medicine of the liver.

再生医学的目的是恢复有缺陷器官的功能,而不需要替换它,即不需要切除移植,而是通过使用健康细胞将缺陷功能转移到患病器官内。细胞可以成熟,直接从源组织中获取,也可以从干细胞中产生,干细胞可以在体外操作,扩增和/或分化以使其发挥功能。肝细胞治疗证明了代谢活性缺陷可以通过门静脉输入异体肝细胞转移。该技术的主要局限性包括器官短缺、成熟细胞的更新能力差和低温保存的抵抗力差。最近在成人肝脏中发现了一种肝源性祖细胞。该细胞通过培养过程选择,可以在体外扩增,并在移植到啮齿动物肝脏时分化为成熟的人肝细胞。该细胞具有肝细胞的全部基本功能,可代替成熟的肝细胞用于肝脏的再生医学。
{"title":"[Regeneration of the liver: from hepatocyte cells to deficient hepatic cells].","authors":"E M Sokal","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Regenerative medicine aims to restore the function of a deficient organ without replacing it, i.e. without resection-transplantation, but by the use of healthy cells which will transfer the deficient function inside the diseased organ. Cells can be mature, harvested directly from the source tissue, or be instead produced from stem cells, which can be manipulated in vitro, expanded and/or differentiated to render them functional. Liver cell therapy has brought the proof of concept that a deficient metabolic activity can be transferred via transfusion of heterologous liver cells via the portal vein. The main limitations of the technique include organ shortage, poor renewal capacity of mature cells and poor resistance to cryopreservation. A liver derived progenitor cell has recently been identified in the adult human liver. The cell is selected by a culture process, can be expanded in vitro and differentiated into mature human hepatocytes when transplanted in rodent livers. The cell displays all the essential hepatocyte function, and may replace the mature hepatocyte for regenerative medicine of the liver.</p>","PeriodicalId":75641,"journal":{"name":"Bulletin et memoires de l'Academie royale de medecine de Belgique","volume":"164 5-6","pages":"207-12; discussion 213"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29150808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ethical reflections relating to management of a crisis like a pandemic of influenza]. [与流感大流行等危机管理有关的伦理思考]。
J-A Stiennon-Heuson
{"title":"[Ethical reflections relating to management of a crisis like a pandemic of influenza].","authors":"J-A Stiennon-Heuson","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":75641,"journal":{"name":"Bulletin et memoires de l'Academie royale de medecine de Belgique","volume":"164 10","pages":"295-9"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29156991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[General medicine in the 21st century]. [21世纪的全科医学]。
D Giet, D Pestiaux, M Schetgen

General medicine is the main pivot of our healthcare system. General practitioners' tasks are numerous: front line responsibility, networking coordination, long-term patient care, community medicine and also primary care research. In the framework of general medicine that has been undergoing profound change for many years, we have chosen to develop three of these facets: general practitioners' knowledge of family, psychological, social or environmental factors and their capacity to coordinate with other health workers will help them in their primary and secondary prevention and also quaternary work by sparing patients unnecessary treatment and examinations. General medicine will increasingly become a discipline, one of which specific expertise will be to manage bio-psycho-societal complexity. Multidisciplinary action will be the rule: general practitioners will no longer be able to claim they can deal with all the curative, preventive and health education tasks. And the research in general medicine is essential because general practitioners can deal with over 80% of the health problems identified by patients and because the symptoms leading to the treatment cannot only be studied by laboratory or hospital research.

全科医学是我国医疗保健体系的支柱。全科医生的任务很多:一线责任、网络协调、长期病人护理、社区医学以及初级保健研究。在多年来经历了深刻变化的全科医学框架中,我们选择发展其中的三个方面:全科医生对家庭、心理、社会或环境因素的知识以及他们与其他卫生工作者协调的能力,将有助于他们进行一级和二级预防,并通过减少患者不必要的治疗和检查来进行四级工作。普通医学将日益成为一门学科,其中一门专门的专业知识将是管理生物、心理和社会的复杂性。多学科行动将成为规则:全科医生将不再能够声称他们能够处理所有的治疗、预防和健康教育任务。全科医学的研究是必不可少的,因为全科医生可以处理80%以上的病人确定的健康问题,因为导致治疗的症状不能仅仅通过实验室或医院研究来研究。
{"title":"[General medicine in the 21st century].","authors":"D Giet,&nbsp;D Pestiaux,&nbsp;M Schetgen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>General medicine is the main pivot of our healthcare system. General practitioners' tasks are numerous: front line responsibility, networking coordination, long-term patient care, community medicine and also primary care research. In the framework of general medicine that has been undergoing profound change for many years, we have chosen to develop three of these facets: general practitioners' knowledge of family, psychological, social or environmental factors and their capacity to coordinate with other health workers will help them in their primary and secondary prevention and also quaternary work by sparing patients unnecessary treatment and examinations. General medicine will increasingly become a discipline, one of which specific expertise will be to manage bio-psycho-societal complexity. Multidisciplinary action will be the rule: general practitioners will no longer be able to claim they can deal with all the curative, preventive and health education tasks. And the research in general medicine is essential because general practitioners can deal with over 80% of the health problems identified by patients and because the symptoms leading to the treatment cannot only be studied by laboratory or hospital research.</p>","PeriodicalId":75641,"journal":{"name":"Bulletin et memoires de l'Academie royale de medecine de Belgique","volume":"163 7-9","pages":"425-31"},"PeriodicalIF":0.0,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28176405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Medical history of a Florentine dynasty: the Medici]. [佛罗伦萨王朝的医学史:美第奇王朝]。
I De Leeuw

The family of the Medici has dominated the city of Florence from the 15th to the 18th century. With the fortune accumulated by their bank, their trade and industry, they made Florence the European capital of the Renaissance and one of the world centres of culture. However, the Medici got a lot of health problems that have often influenced the destiny of the city and its citizens. During the 15th century, the Medici of Cafaggiolo branch of the family were the uncrowned masters of the Florence republic. All got major "rheumatic" complaints, who often interfered with a normal professional activity. The tradition called their disease "gout" and one of the Medici even received the nickname "the gouty" (Piero il Gottoso). Radiological and pathological exploration of the bones, the study of documents from ocular witnesses and the icon pathological study of paintings of the family could however not confirm this diagnosis. On the contrary, 2 other osteo-articular syndromes could be disclosed in the family. During the 16th century, the Medici became Grandukes of Tuscany with absolute political power, abandoning their classical jobs as bankers and traders. Their luxurious life with feasts and lewdness induces their progressive fall that will be accelerated by illness. Malaria, the plague, venereal diseases, madness and cardiovascular disease decimate the family as well as murders, poisonings and other criminal acts. Moreover, the physical resistance of the family decreased due to some underlying, hereditary pathologies that were recently discovered. In 1737, the last Granduke died in a state of complete marasmus and Florence is taken over by the house of Lorraine.

从15世纪到18世纪,美第奇家族一直统治着佛罗伦萨。凭借他们的银行、贸易和工业积累的财富,他们使佛罗伦萨成为文艺复兴时期的欧洲首都和世界文化中心之一。然而,美第奇家族有很多健康问题,这些问题经常影响到这座城市及其公民的命运。在15世纪,卡法乔洛家族的美第奇家族是佛罗伦萨共和国的无冕之王。所有人都有严重的“风湿病”症状,经常干扰正常的职业活动。传统上称他们的疾病为“痛风”,其中一位美第奇家族成员甚至得到了“痛风”的绰号(皮耶罗·伊尔·戈托索)。然而,骨骼的放射学和病理学探索,来自目击者的文件研究和家庭绘画的图标病理学研究都不能证实这一诊断。相反,家族中可发现2种其他骨关节综合征。在16世纪,美第奇家族放弃了银行家和商人的传统工作,成为了拥有绝对政治权力的托斯卡纳大公。他们的奢侈生活与盛宴和淫荡导致他们的逐步下降,将加速疾病。疟疾、瘟疫、性病、疯癫和心血管疾病以及谋杀、投毒和其他犯罪行为使家庭毁灭。此外,由于最近发现的一些潜在的遗传疾病,该家族的身体抵抗力下降了。1737年,最后一位大公爵在完全消瘦的状态下去世,佛罗伦萨被洛林家族接管。
{"title":"[Medical history of a Florentine dynasty: the Medici].","authors":"I De Leeuw","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The family of the Medici has dominated the city of Florence from the 15th to the 18th century. With the fortune accumulated by their bank, their trade and industry, they made Florence the European capital of the Renaissance and one of the world centres of culture. However, the Medici got a lot of health problems that have often influenced the destiny of the city and its citizens. During the 15th century, the Medici of Cafaggiolo branch of the family were the uncrowned masters of the Florence republic. All got major \"rheumatic\" complaints, who often interfered with a normal professional activity. The tradition called their disease \"gout\" and one of the Medici even received the nickname \"the gouty\" (Piero il Gottoso). Radiological and pathological exploration of the bones, the study of documents from ocular witnesses and the icon pathological study of paintings of the family could however not confirm this diagnosis. On the contrary, 2 other osteo-articular syndromes could be disclosed in the family. During the 16th century, the Medici became Grandukes of Tuscany with absolute political power, abandoning their classical jobs as bankers and traders. Their luxurious life with feasts and lewdness induces their progressive fall that will be accelerated by illness. Malaria, the plague, venereal diseases, madness and cardiovascular disease decimate the family as well as murders, poisonings and other criminal acts. Moreover, the physical resistance of the family decreased due to some underlying, hereditary pathologies that were recently discovered. In 1737, the last Granduke died in a state of complete marasmus and Florence is taken over by the house of Lorraine.</p>","PeriodicalId":75641,"journal":{"name":"Bulletin et memoires de l'Academie royale de medecine de Belgique","volume":"163 10-12","pages":"499-508"},"PeriodicalIF":0.0,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28684007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Bulletin et memoires de l'Academie royale de medecine de Belgique
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1